D-1050-2017 Class II Terminated
FDA drug recall D-1050-2017 was initiated by Bayer HealthCare Pharmaceuticals, Inc. on March 30, 2017 and is designated Class II. Reason for recall: Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs. The recall status is terminated (terminated January 8, 2020). Affected quantity: 24,672 24-count cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- August 9, 2017
- Initiation Date
- March 30, 2017
- Termination Date
- January 8, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24,672 24-count cartons
Product Description
Alka-Seltzer Extra Strength (500 mg Aspirin (NSAID), 1985 mg Analgesic Sodium bicarbonate/Antacid, 1000 mg Anhydrous Citric Acid) Effervescent Tablets, 24-count carton, Made in Germany, Distributed by Bayer HealthCare, LLC Whippany, NJ 07981, UPC 016500044048
Reason for Recall
Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.
Distribution Pattern
Nationwide
Code Information
BTAHDG0; Exp. 04/19